Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

Clinical Endocrinology

Volumn 61, Issue 6, 2004, Pages 700-703

  Targher, Giovanni ^a,b   Bertolini, Lorenzo ^a   Scala, Luca ^a   Poli, Felice ^c   Zenari, Luciano ^a   Falezza, Giancarlo ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Osp 'Sacro Cuore Don G Calabria' ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MIDDLE AGED; OBESITY;

EID: 10844246291     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02151.x     Document Type: Article

References (12)

1. Angulo, P. (2002) Nonalcoholic fatty liver disease. New England Journal of Medicine, 346, 1221-1231.
2. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. & Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
3. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, E, Zenere, B.M., Monauni, T. & Muggeo, M. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63.
4. Chandran, M., Phillips, S.A., Ciaraldi, T. & Henry, R.R. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care, 26, 2442-2450.
5. Cigolini, M., Targher, G., Agostino, G., Tonoli, M., Muggeo, M. & De Sandre, G. (1996) Liver steatosis and its relation to plasma haemostatic factors in apparently healthy males. Role of the metabolic syndrome. Thrombosis and Haemostasis, 76, 69-73.
6. Fasshauer, M. & Paschke, R. (2003) Regulation of adipocytokines and insulin resistance. Diabetologia, 46, 1594-1603.
7. Lopez-Bermejo, A., Botas, P., Funahashi, T., Delgado, E., Kihara, S., Ricart, W. & Fernández-Real, J.M. (2004) Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clinical Endocrinology (Oxford), 60, 256-263.
8. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N. & Rizzetto, M. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37, 917-923.
9. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B. & Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association, 291, 1730-1737.
10. Xu, A., Wang, Y., Keshaw, H., Xu, L.Y., Lam, K.S.L. & Cooper, G.J.S. (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. Journal of Clinical Investigation, 112, 91-100.
11. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y, Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Retman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. & Kadowaki, T. (2001) The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7, 941-946.
12. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Uechi, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B. & Kadowaki, T. (2002) Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8, 1288-1295.